PharmaCyte Biotech, Inc.PMCBNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank36
Year-over-Year Change
Year-over-year operating cash flow growth rate
Percentile
P36
Within normal range
vs 5Y Ago
-2x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -38.43% |
| 2024 | 43.29% |
| 2023 | 7.86% |
| 2022 | -23.61% |
| 2021 | -42.44% |
| 2020 | 18.75% |
| 2019 | 43.34% |
| 2018 | -52.10% |
| 2017 | 23.17% |
| 2016 | 4.69% |